(Q82251073)
Statements
Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126 (English)
John A Sandoval
Patrick J Klein
Heather A Woodruff
Jay L Grosfeld
Robert J Hickey
Linda H Malkas